Voyager Therapeutics (VYGR) Assets (2014 - 2026)
Voyager Therapeutics (VYGR) posted Assets of $219.3 million for Q1 2026, down 13.06% sequentially from $252.3 million in Q4 2025, and down 37.91% YoY from $353.2 million in Q1 2025.
Voyager Therapeutics (VYGR) Assets (2014 - 2026) Analysis & Trends
Voyager Therapeutics has reported Assets for 13 years, with the latest figure at $219.3 million in Q1 2026.
- Quarterly Assets fell 37.91% year-over-year to $219.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $219.3 million (down 37.91% YoY) and the FY2025 annual result came in at $252.3 million, down 35.81% from the prior year.
- Assets slipped to $219.3 million in Q1 2026 per VYGR's latest filing, from $252.3 million in the prior quarter.
- Over five years, Assets peaked at $469.6 million in Q1 2024 and troughed at $159.4 million in Q4 2022.
- A 5-year average of $306.6 million and a median of $315.5 million in 2023 frame the typical range for Assets.
- The sharpest annual moves came in 2023 and 2026: Assets surged 120.44% in 2023, then sank 37.91% in 2026.
- Over 5 years, Assets stood at $159.4 million in 2022, then soared by 120.44% to $351.3 million in 2023, then climbed by 11.89% to $393.0 million in 2024, then plunged by 35.81% to $252.3 million in 2025, then decreased by 13.06% to $219.3 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $219.3 million, $252.3 million, and $288.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Voyager Therapeutics | 201.32 Mn | 84.98 Mn | - | 197.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 197.75 Mn |
| Mar 31, 2026 | 219.33 Mn |
| Dec 31, 2025 | 252.28 Mn |
| Sep 30, 2025 | 288.31 Mn |
| Jun 30, 2025 | 322.10 Mn |
| Mar 31, 2025 | 353.24 Mn |
| Dec 31, 2024 | 393.05 Mn |
| Sep 30, 2024 | 426.04 Mn |
| Jun 30, 2024 | 436.23 Mn |
| Mar 31, 2024 | 469.59 Mn |
| Dec 31, 2023 | 351.28 Mn |
| Sep 30, 2023 | 294.65 Mn |
| Jun 30, 2023 | 315.54 Mn |
| Mar 31, 2023 | 336.29 Mn |
| Dec 31, 2022 | 159.36 Mn |
| Sep 30, 2022 | 182.48 Mn |
| Jun 30, 2022 | 188.61 Mn |
| Mar 31, 2022 | 224.18 Mn |
| Dec 31, 2021 | 193.86 Mn |
| Sep 30, 2021 | 184.77 Mn |